期刊
RSC MEDICINAL CHEMISTRY
卷 13, 期 5, 页码 568-584出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/d1md00374g
关键词
-
资金
- CNPq [454088/2014-0, 400271/2014-1, 310082/2016-1, 406739/2018-8, 303804/2020-3]
- FAPEMIG [CEX-APQ-00241-15, CEX -APQ-00518-17]
- FINEP
- INCT-INOFAR [465.249/2014-0]
- Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brazil (CAPES) [001]
- PRPPG-UNIFAL
A new series of multifunctional thalidomide-donepezil hybrids were synthesized and evaluated for their potential neuroprotective, cholinesterase inhibitory, and anti-neuroinflammatory effects. The most promising compound, PQM-189 (3g), showed good inhibitory activity and decreased inflammation levels. These findings suggest that compound PQM-189 (3g) may be a promising agent for neuroinflammation and neuroprotection.
A new series of eight multifunctional thalidomide-donepezil hybrids were synthesized based on the multitarget-directed ligand strategy and evaluated as potential neuroprotective, cholinesterase inhibitors and anti-neuroinflammatory agents against neurodegenerative diseases. A molecular hybridization approach was used for structural design by combining the N-benzylpiperidine pharmacophore of donepezil and the isoindoline-1,3-dione fragment from the thalidomide structure. The most promising compound, PQM-189 (3g), showed good AChE inhibitory activity with an IC50 value of 3.15 mu M, which was predicted by docking studies as interacting with the enzyme in the same orientation observed in the AChE-donepezil complex and a similar profile of interaction. Additionally, compound 3g significantly decreased iNOS and IL-1 beta levels by 43% and 39%, respectively, after 24 h of incubation with lipopolysaccharide. in vivo data confirmed the ability of 3g to prevent locomotor impairment and changes in feeding behavior elicited by lipopolysaccharide. Moreover, the PAMPA assay evidenced adequate blood-brain barrier and gastrointestinal tract permeabilities with an Fa value of 69.8%. Altogether, these biological data suggest that compound 3g can treat the inflammatory process and oxidative stress resulting from the overexpression of iNOS and therefore the increase in reactive nitrogen species, and regulate the release of pro-inflammatory cytokines such as IL-1 beta. In this regard, compound PQM-189 (3g) was revealed to be a promising neuroprotective and anti-neuroinflammatory agent with an innovative thalidomide-donepezil-based hybrid molecular architecture.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据